News
Hospitals are zeroing in on alternative care models to improve the nursing work experience and patient outcomes while ...
FDA Grants Priority Review to Regeneron’s Eylea for Macular Edema Following Retinal Vein Occlusion
Regulatory action was based on data from the Phase III QUASAR trial, which demonstrated that Eylea HD dosed every eight weeks ...
EYLEA ® (aflibercept) Injection 2 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion ...
The VA looks like it is changing course on a plan that would have threatened the privacy of veterans receiving mental health ...
There are some new x-rays in the radiology department at Novant Health Rowan Medical Center, but they aren’t your typical ...
Huntington's Disease Treatment Market To Hit $2.03 Billion By 2033, Driven By Cutting-Edge Therapies
Factors driving the market include rising disease prevalence, innovative therapies, and gene-based treatment breakthroughs. Key players like H Lundbe ...
Vermont had the lowest rate of cardiac stress tests performed before low-risk outpatient procedures between July 1, 2022, and June 30, 2023, according to CMS data released Feb. 19. CMS measures the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results